Lantheus Holdings (LNTH) Receivables - Net (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Receivables - Net of $355.7 million for Q1 2026, up 1.98% year-over-year from $348.7 million in Q1 2025, and down 0.83% quarter-over-quarter from $358.6 million in Q4 2025.
Lantheus Holdings (LNTH) Receivables - Net (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Receivables - Net for 13 consecutive years, with $355.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net rose 1.98% year-over-year to $355.7 million; the TTM figure through Mar 2026 stood at $355.7 million (up 1.98% YoY), while the FY2025 annual figure was $358.6 million, up 11.64% from the prior year.
- Receivables - Net fell to $355.7 million in Q1 2026 per LNTH's latest filing, from $358.6 million in the prior quarter.
- Across five years, Receivables - Net topped out at $372.3 million in Q2 2024 and bottomed at $172.3 million in Q1 2022.
- Historically, Receivables - Net has averaged $289.6 million across 5 years, with a median of $321.3 million in 2024.
- Annual changes were most pronounced in 2022 — Receivables - Net jumped 240.76% — and 2025, when it slipped 9.59%.
- Lantheus Holdings' Receivables - Net stood at $213.4 million in 2022, then surged by 33.22% to $284.3 million in 2023, then gained by 13.0% to $321.3 million in 2024, then gained by 11.64% to $358.6 million in 2025, then retreated by 0.83% to $355.7 million in 2026.
- Business Quant data shows LNTH's Receivables - Net at $355.7 million in Q1 2026, $358.6 million in Q4 2025, and $351.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.73 Bn | 40.07 Bn | 2.15 Bn |
| 3 | Zoetis | 32.51 Bn | 30.83 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn |
| 6 | Viatris | 19.01 Bn | 18.13 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Lantheus Holdings | 6.53 Bn | 5.94 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 352.89 Mn |
| Jun 30, 2026 | 352.89 Mn |
| Mar 31, 2026 | 355.67 Mn |
| Mar 31, 2026 | 355.67 Mn |
| Dec 31, 2025 | 358.64 Mn |
| Dec 31, 2025 | 358.64 Mn |
| Sep 30, 2025 | 351.38 Mn |
| Sep 30, 2025 | 351.38 Mn |
| Jun 30, 2025 | 336.58 Mn |
| Jun 30, 2025 | 336.58 Mn |
| Mar 31, 2025 | 348.75 Mn |
| Mar 31, 2025 | 348.75 Mn |
| Dec 31, 2024 | 321.26 Mn |
| Dec 31, 2024 | 321.26 Mn |
| Sep 30, 2024 | 329.34 Mn |
| Sep 30, 2024 | 329.34 Mn |
| Jun 30, 2024 | 372.29 Mn |
| Jun 30, 2024 | 372.29 Mn |
| Mar 31, 2024 | 337.39 Mn |
| Mar 31, 2024 | 337.39 Mn |